Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA.
Section of General Internal Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Health Serv Res. 2022 Dec;57 Suppl 2(Suppl 2):235-248. doi: 10.1111/1475-6773.13998. Epub 2022 May 20.
To understand providers' perceptions of how a patient's experience of racism may impact the successful implementation of a brief posttraumatic stress disorder (PTSD) treatment in the safety net integrated primary care setting. To conduct a developmental formative evaluation prior to a hybrid type I effectiveness-implementation trial.
From October 2020 to January 2021, in-depth qualitative interviews were conducted with integrated primary care stakeholders (N = 27) at the largest safety net hospital in New England, where 82% of patients identify as racial or ethnic minorities.
Interviews with clinical stakeholders were used to (a) contextualize current patient and provider experiences and responses to racism, (b) consider how racism may impact PTSD treatment implementation, (c) gather recommendations for potential augmentation to the proposed PTSD treatment (e.g., culturally responsive delivery, cultural adaptation), and (d) gather recommendations for how to shift the integrated primary care practice to an antiracist framework.
DATA COLLECTION/EXTRACTION METHODS: Interview data were gathered using remote data collection methods (video conferencing). Participants were hospital employees, including psychologists, social workers, primary care physicians, community health workers, administrators, and operations managers. We used conventional content analysis.
Clinical stakeholders acknowledged the impact of racism, including racial stress and trauma, on patient engagement and noted the potential need to adapt PTSD treatments to enhance engagement. Clinical stakeholders also characterized the harms of racism on patients and providers and provided recommendations such as changes to staff training and hiring practices, examination of racist policies, and increases in support for providers of color.
This study contextualizes providers' perceptions of racism in the integrated primary care practice and provides some suggestions for shifting to an antiracist framework. Our findings also highlight how racism in health care may be a PTSD treatment implementation barrier.
了解提供者对患者经历种族主义可能如何影响在安全网综合初级保健环境中成功实施简短创伤后应激障碍(PTSD)治疗的看法。在混合 I 型有效性实施试验之前进行发展形成性评估。
2020 年 10 月至 2021 年 1 月,在新英格兰最大的安全网医院对综合初级保健利益相关者(N=27)进行了深入的定性访谈,其中 82%的患者被认定为少数族裔或少数民族。
对临床利益相关者进行访谈,以 (a) 使当前患者和提供者对种族主义的经历和反应背景化,(b) 考虑种族主义如何影响 PTSD 治疗的实施,(c) 收集对拟议 PTSD 治疗的潜在增强建议(例如,文化响应式交付,文化适应),以及 (d) 收集如何将综合初级保健实践转变为反种族主义框架的建议。
数据收集/提取方法:使用远程数据收集方法(视频会议)收集访谈数据。参与者是医院员工,包括心理学家、社会工作者、初级保健医生、社区卫生工作者、管理人员和运营经理。我们使用了常规内容分析。
临床利益相关者承认种族主义的影响,包括种族压力和创伤,对患者参与的影响,并指出可能需要调整 PTSD 治疗以增强参与度。临床利益相关者还描述了种族主义对患者和提供者的危害,并提出了一些建议,例如改变员工培训和招聘实践、审查种族主义政策以及增加对有色人种提供者的支持。
本研究将提供者对综合初级保健实践中种族主义的看法背景化,并为转向反种族主义框架提供了一些建议。我们的研究结果还强调了医疗保健中的种族主义如何成为 PTSD 治疗实施的障碍。